PROMVIAD

Welcome to the Brand page for “PROMVIAD”, which is offered here for Human pharmaceuticals for the treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases and pain, dermatologic disorders, infectious-related diseases, metabolic diseases, gastrointestinal diseases, muscle dystonias, wrinkles and smooth muscle disorders, oncologic diseases, ophthalmic diseases, respiratory diseases; human pharmaceuticals for use as hemostatic agents;.

Its status is currently believed to be active. Its class is unavailable. “PROMVIAD” is believed to be currently owned by “Johnson & Johnson”.